There’s been much discussion and debate about the cuts to Medicaid eligibility that Congress just passed and, in particular, what they may mean for current Medicaid recipients. A key piece…

The Vaccine Integrity Project will convene experts to assess the evidence on influenza, RSV, and Covid-19 to equip clinicians with reliable, evidence-based information.

Here's how the tax-cut bill that’s headed to Trump’s desk would upend health care

Generative AI chatbot for doctors called 'Prof. Valmed' earns E.U. approval. In the U.S., FDA is yet to issue guidelines on the technology's use in medicine.

Michael Worobey.Professor of ecology and evolutionary biology, University of Arizona. Learn more: @MichaelWorobey #STATUSList.

Donald Warne.Director, Johns Hopkins Center for Indigenous Health. Learn more: @donaldwarnemd #STATUSList.

Halidou Tinto.Regional director, IRSS Clinical Research Unit of Nanoro, Burkina Faso. Learn more: @halidou_tinto #STATUSList.

Sarah Teichmann.Head of cellular genetics, Wellcome Sanger Institute. Learn more: @sarahteichmann1 #STATUSList.

Karandeep Singh.Director, Center for Healthcare AI and Data Science, University of Michigan. Learn more: @kdpsinghlab #STATUSList.

Leonardo Seoane.Chief academic officer, Ochsner Health. Learn more: @LeoSeoaneMD #STATUSList.

Dorothy Roberts.Professor of Law and Sociology; Director, Penn Program on Race, Science & Society, University of Pennsylvania. Learn more: @DorothyERoberts #STATUSList.

Timothy Naimi.Director, Canadian Institute for Substance Use Research and professor, Division of Medical Sciences, University of Victoria. Learn more: #STATUSList.

Have you seen who is on the 2025 #STATUSList?.50 influential people shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech. Meet the list members who work in academia. 🧵.Part 2.

Your guide to DC health politics and policy.

And more health news stories of the day.

A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s stance on vaccines

Here is STAT’s biotech scorecard for the third quarter.

The mood in biotech is better than the numbers on Wall Street suggest.

Over 660 million pilgrims gathered at the Maha Kumbh Mela in Prayagraj, India, this past February, and I'm now seeing the downstream consequences in my California clinic. This year, I've…

Forget tariffs. Another tool of economic statecraft is far better suited to the problem of illegally manufactured fentanyl.